Gerresheimer Q2 preliminary revenue €578 million, shares rise after recovery
Gerresheimer reported preliminary Q2 revenue of €578 million, up from €474.9 million in Q1, while half-year EBITDA fell to €168 million; it reiterated a stronger second half after an outlook cut in June.
(Recasts with share move and Q2 revenue recovery in paragraphs 1-2, adds outlook comment in paragraph 3.) Sept 30 (Reuters) — Gerresheimer reported a sequential recovery in its second-quarter revenue on Wednesday, sending its shares 8% higher in early trading, as demand for its drug delivery devices boosted sales. The German drug-packaging maker reported preliminary revenue of €578 million ($656.09 million) for the second quarter, up from €474.9 million in first quarter of the financial year.
The company's half-year earnings before interest, taxes, depreciation and amortisation fell to €168 million from €210.4 million a year ago, but it reiterated that it expected the second half of the year to be stronger, after cutting its outlook in June. ($1 = 0.8810 euros) (Reporting by Kira Britten and Danny Callaghan in Gdansk, editing by Milla Nissi-Prussak) ((Kira.Britten@thomsonreuters.com)